77
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Assessment of Computed Tomography-Defined Muscle and Adipose Tissue Features in Relation to Length of Hospital Stay and Recurrence of Hypertriglyceridemic Pancreatitis

, , , , &
Pages 1709-1717 | Published online: 05 May 2021

References

  • Piwinski S. Severe acute pancreatitis. JAMA. 2004;292(11):1305. doi:10.1001/jama.292.11.1305-a
  • M O, L S, B B, et al. Acute pancreatitis: extrapancreatic necrosis volume as early predictor of severity. Radiology. 2015;276(1):119–128. doi:10.1148/radiol.15141494
  • Jin M, Bai X, Chen X, et al. A 16-year trend of etiology in acute pancreatitis: the increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis. J Clin Lipidol. 2019;13(6):947–953.e1. doi:10.1016/j.jacl.2019.09.005
  • Krishna SG, Hinton A, Oza V, et al. Morbid obesity is associated with adverse clinical outcomes in acute pancreatitis: a propensity-matched Study. Am J Gastroenterol. 2015;110(11):1608–1619. doi:10.1038/ajg.2015.343
  • Xiang JX, Hu LS, Liu P, et al. Impact of cigarette smoking on recurrence of hyperlipidemic acute pancreatitis. World J Gastroenterol. 2017;23(47):8387–8394. doi:10.3748/wjg.v23.i47.8387
  • Zheng Y, Zhou Z, Li H, et al. A multicenter study on etiology of acute pancreatitis in Beijing during 5 years. Pancreas. 2015;44(3):409–414. doi:10.1097/MPA.0000000000000273
  • Valdivielso P, Ramírez-Bueno A, Ewald N. Current knowledge of hypertriglyceridemic pancreatitis. Eur J Intern Med. 2014;25(8):689–694. doi:10.1016/j.ejim.2014.08.008
  • Pothoulakis I, Paragomi P, Archibugi L, et al. Clinical features of hypertriglyceridemia-induced acute pancreatitis in an international, multicenter, prospective cohort (APPRENTICE consortium). Pancreatology. 2020;20(3):325–330. doi:10.1016/j.pan.2020.02.010
  • Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas. 2006;33(4):323–330. doi:10.1097/01.mpa.0000236733.31617.52
  • Diehl AK, Holleman DR Jr, Chapman JB, et al. Gallstone size and risk of pancreatitis. Arch Intern Med. 1997;157(15):1674–1678. doi:10.1001/archinte.1997.00440360088009
  • Havel RJ. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv Intern Med. 1969;15:117–154.
  • Tai WP, Lin XC, Liu H, et al. A retrospective research of the characteristic of hypertriglyceridemic pancreatitis in Beijing, China. Gastroenterol Res Pract. 2016;2016:6263095. doi:10.1155/2016/6263095
  • Goyal H, Smith B, Bayer C, et al. Differences in severity and outcomes between hypertriglyceridemia and alcohol-induced pancreatitis. N Am J Med Sci. 2016;8(2):82–87. doi:10.4103/1947-2714.177307
  • Subramanian S, Chait A. Hypertriglyceridemia secondary to obesity and diabetes. Biochim Biophys Acta. 2012;1821(5):819–825. doi:10.1016/j.bbalip.2011.10.003
  • Martínez J, Johnson CD, Sánchez-Payá J, et al. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6(3):206–209. doi:10.1159/000092104
  • Hansen SEJ, Madsen CM, Varbo A, et al. Body mass index, triglycerides, and risk of acute pancreatitis: a population-based Study of 118 000 individuals. J Clin Endocrinol Metab. 2020;105(1):105. doi:10.1210/clinem/dgz059
  • Dobszai D, Mátrai P, Gyöngyi Z, et al. Body-mass index correlates with severity and mortality in acute pancreatitis: a meta-analysis. World J Gastroenterol. 2019;25(6):729–743. doi:10.3748/wjg.v25.i6.729
  • Blaszczak AM, Krishna SG, Hart PA, et al. Class III obesity rather than metabolic syndrome impacts clinical outcomes of acute pancreatitis: a propensity score weighted analysis. Pancreatology. 2020;20(7):1287–1295. doi:10.1016/j.pan.2020.08.011
  • Thavamani A, Umapathi KK, Roy A, et al. The increasing prevalence and adverse impact of morbid obesity in paediatric acute pancreatitis. Pediatr Obes. 2020;15(8):e12643. doi:10.1111/ijpo.12643
  • Pérez S, Rius-Pérez S, Finamor I, et al. Obesity causes PGC-1α deficiency in the pancreas leading to marked IL-6 upregulation via NF-κB in acute pancreatitis. J Pathol. 2019;247:48–59. doi:10.1002/path.5166
  • Chen SM, Xiong GS, Wu SM. Is obesity an indicator of complications and mortality in acute pancreatitis? An updated meta-analysis. J Dig Dis. 2012;13(5):244–251. doi:10.1111/j.1751-2980.2012.00587.x
  • Sorimachi H, Obokata M, Takahashi N, et al. Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction. Eur Heart J. 2020.
  • Navaneethan SD, Kirwan JP, Remer EM, et al. Adiposity, physical function, and their associations with insulin resistance, inflammation, and adipokines in CKD. Am J Kidney Dis. 2020.
  • Fernandes RA, Li C, Wang G, et al. Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo. Elife. 2020;9:9. doi:10.7554/eLife.58463
  • Anderson WD, Soh JY, Innis SE, et al. Sex differences in human adipose tissue gene expression and genetic regulation involve adipogenesis. Genome Res. 2020;30(10):1379–1392. doi:10.1101/gr.264614.120
  • Klopfenstein BJ, Kim MS, Krisky CM, et al. Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans. Br J Radiol. 2012;85(1018):e826–30. doi:10.1259/bjr/57987644
  • Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. doi:10.1136/gutjnl-2012-302779
  • Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–635. doi:10.1016/S1470-2045(08)70153-0
  • Bhatia M, Wong FL, Cao Y, et al. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5(2–3):132–144. doi:10.1159/000085265
  • Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(5):1179–1187.e3. doi:10.1053/j.gastro.2012.08.002
  • Scherer J, Singh VP, Pitchumoni CS, et al. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol. 2014;48(3):195–203. doi:10.1097/01.mcg.0000436438.60145.5a
  • Li J, Chen J, Tang W. The consensus of integrative diagnosis and treatment of acute pancreatitis-2017. J Evid Based Med. 2019;12(1):76–88. doi:10.1111/jebm.12342
  • Filippatos T, Milionis HJ. Treatment of hyperlipidaemia with fenofibrate and related fibrates. Expert Opin Investig Drugs. 2008;17(10):1599–1614. doi:10.1517/13543784.17.10.1599
  • Kim SI, Kim TM, Lee M, et al. Impact of CT-determined sarcopenia and body composition on survival outcome in patients with advanced-stage high-grade serous ovarian carcinoma. Cancers (Basel). 2020;12.
  • Gupta P, Dawra S, Chandel K, et al. Fat-modified computed tomography severity index (CTSI) is a better predictor of severity and outcome in patients with acute pancreatitis compared with modified CTSI. Abdom Radiol (NY). 2020;45(5):1350–1358. doi:10.1007/s00261-020-02473-y
  • Sadr-Azodi O, Orsini N, Andrén-Sandberg Å, et al. Abdominal and total adiposity and the risk of acute pancreatitis: a population-based prospective cohort study. Am J Gastroenterol. 2013;108(1):133–139. doi:10.1038/ajg.2012.381
  • Monreal-Robles R, Kohn-Gutiérrez AE, Sordia-Ramírez J, et al. Peritoneal cavity circumference on computed tomography predicts outcomes in acute pancreatitis. Eur J Radiol. 2020;132:109327. doi:10.1016/j.ejrad.2020.109327
  • Sternby H, Mahle M, Linder N, et al. Mean muscle attenuation correlates with severe acute pancreatitis unlike visceral adipose tissue and subcutaneous adipose tissue. United European Gastroenterol J. 2019;7(10):1312–1320. doi:10.1177/2050640619882520
  • Hall TC, Stephenson JS, Jones MJ, et al. Is abdominal fat distribution measured by axial CT imaging an indicator of complications and mortality in acute pancreatitis? J Gastrointest Surg. 2015;19(12):2126–2131. doi:10.1007/s11605-015-2972-3
  • Duarte-Rojo A, Sosa-Lozano LA, Saul A, et al. Methods for measuring abdominal obesity in the prediction of severe acute pancreatitis, and their correlation with abdominal fat areas assessed by computed tomography. Aliment Pharmacol Ther. 2010;32(2):244–253. doi:10.1111/j.1365-2036.2010.04321.x
  • Szentesi A, Párniczky A, Vincze Á, et al. Multiple hits in acute pancreatitis: components of metabolic syndrome synergize each other’s deteriorating effects. Front Physiol. 2019;10:1202. doi:10.3389/fphys.2019.01202
  • Murata A, Ohtani M, Muramatsu K, et al. Impact of obesity on outcomes of paediatric acute pancreatitis based on a national administrative database. Pediatr Obes. 2016;11(3):174–180. doi:10.1111/ijpo.12041
  • Fujisawa T, Kagawa K, Hisatomi K, et al. Obesity with abundant subcutaneous adipose tissue increases the risk of post-ERCP pancreatitis. J Gastroenterol. 2016;51(9):931–938. doi:10.1007/s00535-016-1160-x
  • Chandrasekar B, Boylston WH, Venkatachalam K, et al. Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression. J Biol Chem. 2008;283(36):24889–24898. doi:10.1074/jbc.M804236200
  • Folco EJ, Rocha VZ, López-Ilasaca M, et al. Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem. 2009;284(38):25569–25575. doi:10.1074/jbc.M109.019786
  • Araki H, Nishihara T, Matsuda M, et al. Adiponectin plays a protective role in caerulein-induced acute pancreatitis in mice fed a high-fat diet. Gut. 2008;57(10):1431–1440. doi:10.1136/gut.2007.135665
  • Wade TE, Mathur A, Lu D, et al. Adiponectin receptor-1 expression is decreased in the pancreas of obese mice. J Surg Res. 2009;154(1):78–84. doi:10.1016/j.jss.2008.05.006
  • Shimonov M, Abtomonova Z, Groutz A, et al. Associations between body composition and prognosis of patients admitted because of acute pancreatitis: a retrospective study. Eur J Clin Nutr. 2020. doi:10.1038/s41430-020-00789-y
  • Ahmed Ali U, Issa Y, Hagenaars JC, et al. Risk of recurrent pancreatitis and progression to chronic pancreatitis after a first episode of acute pancreatitis. Clin Gastroenterol Hepatol. 2016;14(5):738–746. doi:10.1016/j.cgh.2015.12.040
  • Cho JH, Jeong YH, Kim KH, et al. Risk factors of recurrent pancreatitis after first acute pancreatitis attack: a retrospective cohort study. Scand J Gastroenterol. 2020;55(1):90–94. doi:10.1080/00365521.2019.1699598